FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Medicis Pharmaceutical CLENZIderm M Recall

CLENZIderm M

Medicis Pharmaceutical Corp · Scottsdale, AZ

Risk level
Class II
Reported by FDA
Aug 28, 2013
Recall ID
D-916-2013
Check your lot numberHow we source this data

Summary

Medicis Pharmaceutical recalled CLENZIderm M starting May 1, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-916-2013 on Aug 28, 2013. Reason: cGMP Deviations; during the production process, CLENZIderm M.D. Daily Foam Cleanser was filled into some bottles labeled as CLENZIderm M.D. Pore Therapy. Status: Terminated.

Why it was recalled

cGMP Deviations; during the production process, CLENZIderm M.D. Daily Foam Cleanser was filled into some bottles labeled as CLENZIderm M.D. Pore Therapy

Product description

CLENZIderm M.D. Acne Therapeutic System Normal to Oily Skin kit, Distributed by OMP, Inc., Long Beach, CA 90806, Kit is comprised of: Daily Care Foaming Cleanser (Salicylic Acid 2%) NDC 62032-111; Pore Therapy (Salicylic Acid 2%) NDC 62032-110 and Therapeutic Lotion (Benzoyl Peroxide 5%) NDC 562032-113). Product under recall is the Pore Therapy (Salicylic Acid 2%), NDC 62032-110.

Lot numbers, UPCs & expiration codes

Lot #11L1074, NDC 62032-110; Expanded 8/29/2013 to include Lot 11J1075, NDC 62032-511, Exp. 10/14.

Where it was sold

Nationwide, Great Britain, Mexico, Russia and The Ukraine.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-916-2013
Classification
Class II
Status
Terminated
Recall initiated
May 1, 2013
FDA report date
Aug 28, 2013
Quantity
2491 Kits; Expanded 8/29/2013 to include an additional 907 units.
Recall type
Voluntary: Firm initiated
Recalling firm
Medicis Pharmaceutical Corp

Original FDA data

Every field from FDA enforcement report D-916-2013, exactly as published.

Show all FDA fields
City
Scottsdale
State
AZ
Status
Terminated
Country
United States
Event ID
65559
Address
7720 N Dobson Rd
Code information
Lot #11L1074, NDC 62032-110; Expanded 8/29/2013 to include Lot 11J1075, NDC 62032-511, Exp. 10/14.
Postal code
85256-2740
Report date
Aug 28, 2013
Product type
Drugs
Recall number
D-916-2013
Classification
Class II
Recalling firm
Medicis Pharmaceutical Corp
Product quantity
2491 Kits; Expanded 8/29/2013 to include an additional 907 units.
Termination date
Apr 15, 2014
Reason for recall
cGMP Deviations; during the production process, CLENZIderm M.D. Daily Foam Cleanser was filled into some bottles labeled as CLENZIderm M.D. Pore Therapy
Voluntary / mandated
Voluntary: Firm initiated
Product description
CLENZIderm M.D. Acne Therapeutic System Normal to Oily Skin kit, Distributed by OMP, Inc., Long Beach, CA 90806, Kit is comprised of: Daily Care Foaming Cleanser (Salicylic Acid 2%) NDC 62032-111; Pore Therapy (Salicylic Acid 2%) NDC 62032-110 and Therapeutic Lotion (Benzoyl Peroxide 5%) NDC 562032-113). Product under recall is the Pore Therapy (Salicylic Acid 2%), NDC 62032-110.
Distribution pattern
Nationwide, Great Britain, Mexico, Russia and The Ukraine.
Recall initiation date
May 1, 2013
Initial firm notification
Telephone
Center classification date
Aug 22, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-916-2013, published Aug 28, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls